- Additional Proxy Soliciting Materials (definitive) (DEFA14A)
September 30 2009 - 8:55AM
Edgar (US Regulatory)
UNITED
STATES
|
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D.C. 20549
|
|
SCHEDULE 14A
|
|
Proxy
Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
|
|
Filed by the Registrant
x
|
|
Filed by a Party other than the
Registrant
o
|
|
Check the appropriate box:
|
o
|
Preliminary Proxy Statement
|
o
|
Confidential, for
Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
o
|
Definitive Proxy Statement
|
x
|
Definitive Additional Materials
|
o
|
Soliciting Material Pursuant to
§240.14a-12
|
|
ImmunoGen,
Inc.
|
(Name
of Registrant as Specified In Its Charter)
|
|
|
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|
Payment of Filing Fee (Check the
appropriate box):
|
x
|
No fee required.
|
o
|
Fee computed on table below per
Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to
which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to
which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying
value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth
the amount on which the filing fee is calculated and state how it was
determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of
transaction:
|
|
|
|
|
(5)
|
Total fee paid:
|
|
|
|
o
|
Fee paid previously with preliminary
materials.
|
o
|
Check box if any part of the fee is
offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing
for which the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the Form or Schedule and the date
of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration
Statement No.:
|
|
|
|
|
(3)
|
Filing Party:
|
|
|
|
|
(4)
|
Date Filed:
|
|
|
|
|
|
|
|
|
M16523-P83491
Meeting Information Meeting Type: Annual For holders as of: 9/16/2009 Date:
11/11/2009 Time: 11:00 AM Location: You are receiving this communication
because you hold shares in the above named company. This is not a ballot. You
cannot use this notice to vote these shares. This communication presents only
an overview of the more complete proxy materials that are available to you on
the Internet. You may view the proxy materials online at www.proxyvote.com or
easily request a paper copy (see reverse side). We encourage you to access
and review all of the important information contained in the proxy materials
before voting. See the reverse side of this notice to obtain proxy materials
and voting instructions. IMMUNOGEN, INC. *** Exercise Your Right to Vote ***
IMPORTANT NOTICE Regarding the Availability of Proxy Materials Corporate HQ
830 Winter St. Waltham, MA 02451 IMMUNOGEN, INC. 830 WINTER STREET WALTHAM,
MA 02451
|
|
M16524-P83491
Proxy Materials Available to VIEW or RECEIVE: NOTICE AND PROXY STATEMENT
ANNUAL REPORT Before You Vote How to Access the Proxy Materials How To Vote
Please Choose One of the Following Voting Methods Vote In Person: Many
shareholder meetings have attendance requirements including, but not limited
to, the possession of an attendance ticket issued by the entity holding the
meeting. Please check the meeting materials for any special requirements for
meeting attendance. At the Meeting you will need to request a ballot to vote
these shares. Vote By Internet: To vote now by Internet, go to
www.proxyvote.com. Have the 12 Digit Control Number available and follow the
instructions. Vote By Mail: You can vote by mail by requesting a paper copy
of the materials, which will include a proxy card. Requests, instructions and
other inquiries sent to this e-mail address will NOT be forwarded to your
investment advisor. Please make the request as instructed above on or before
10/28/2009 to facilitate timely delivery. How to View Online: Have the
12-Digit Control Number available (located on the following page) and visit:
www.proxyvote.com. How to Request and Receive a PAPER or E-MAIL Copy: If you
want to receive a paper or e-mail copy of these documents, you must request
one. There is NO charge for requesting a copy. Please choose one of the
following methods to make your request: 1) BY INTERNET: www.proxyvote.com 2)
BY TELEPHONE: 1-800-579-1639 3) BY E-MAIL*: sendmaterial@proxyvote.com * If
requesting materials by e-mail, please send a blank e-mail with the 12-Digit
Control Number (located on the following page) in the subject line.
|
|
Voting Items
M16525-P83491 NOTE: Such other business as may properly come before the
meeting or any adjournment thereof. 1. To fix the number of members of the
Board of Directors at nine (9) 01) Mitchel Sayare, Ph.D. 02) David W. Carter
03) Mark Skaletsky 04) Joseph J. Villafranca, Ph.D. 05) Nicole Onetto, MD 2.
Election of Directors Nominees: 06) Stephen C. McCluski 07) Richard J.
Wallace 08) Daniel M. Junius 09) Howard H. Pien 3. To approve an amendment to
the Restated Articles of Organization to increase the number of authorized
shares of common stock from 75,000,000 to 100,000,000 The Board of Directors
recommends that you vote FOR the following: The Board of Directors recommends
you vote FOR the following proposal(s):
|
|
M16526-P83491
|
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Jul 2023 to Jul 2024